Development and Evaluation of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and Polycaprolactone Microparticles of Nimodipine

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|41|7264-7270

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.41, 2013-12, pp. : 7264-7270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Poly(3-hydroxybutyrate)-chitosan: a new biodegradable composition for prolonged delivery of biologically active substances

By Ivantsova E.  

Pharmaceutical Chemistry Journal, Vol. 45, Iss. 1, 2011-04 ,pp. : 51-55

Springer Publishing Company

Access to resources Recommend Favorite

Development and evaluation of novel buccoadhesive wafers of nimodipine for treatment of hypertension

By Hassan Nisreen   Ali Mushir   Ali Javed  

Drug Delivery, Vol. 17, Iss. 2, 2010-02 ,pp. : 59-67

Informa Healthcare

Access to resources Recommend Favorite

Development and Evaluation of High Bioavailable Sustained-Release Nimodipine Tablets Prepared with Monolithic Osmotic Pump Technology

By  

Current Drug Delivery, Vol. 15, Iss. 1, 2018-01 ,pp. : 44-51

Bentham Science Publishers

Access to resources Recommend Favorite

Modification of Biodegradable Poly(Malate) and Poly(Lactic-co-Glycolic Acid) Microparticles with Low Molecular Polyethylene Glycol

By Yoncheva Krassimira   Lambov Nikolai   Miloshev Stoian  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 4, 2009-04 ,pp. : 449-454

Informa Healthcare

Access to resources Recommend Favorite

Development and In Vitro Evaluation of Surface Modified Poly(lactide-co-glycolide) Nanoparticles with Chitosan-4-Thiobutylamidine

By Grabovac Vjera   Bernkop-Schnürch Andreas  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 7, 2007-07 ,pp. : 767-774

Informa Healthcare

Access to resources Recommend Favorite